SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-226971
Filing Date
2024-09-26
Accepted
2024-09-26 16:30:56
Documents
2
Group Members
AVICENNA LIFE SCI MASTER FUND LPAVICENNA LIFE SCI MASTER GP LLCINVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.RAYMOND DEBBANESIREN, L.L.C.ULYS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G d882592dsc13g.htm SC 13G 133603
2 EX-1 d882592dex991.htm EX-99.1 10181
  Complete submission text file 0001193125-24-226971.txt   145665
Mailing Address THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 212-371-1717
Invus Global Management, LLC (Filed by) CIK: 0002005369 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Subject) CIK: 0002023658 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94620 | Film No.: 241329408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)